Odyssey Therapeutics

Odyssey Therapeutics company information, Employees & Contact Information

At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine. In response to recent recruitment fraud, visit our Careers page to verify all job opportunities and read our guidance on this topic: https://odysseytx.com/careers/

Company Details

Employees
138
Founded
-
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Looking for a particular Odyssey Therapeutics employee's phone or email?

Odyssey Therapeutics Questions

News

Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies - Yahoo Finance

Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies Yahoo Finance

Odyssey Therapeutics Raises $213 Million Series D - citybiz

Odyssey Therapeutics Raises $213 Million Series D citybiz

Jeito Capital announces significant participation in oversubscribed $213M Series D financing for Odyssey Therapeutics to advance clinical pipeline addressing autoimmune diseases with high unmet needs - GlobeNewswire

Jeito Capital announces significant participation in oversubscribed $213M Series D financing for Odyssey Therapeutics to advance clinical pipeline addressing autoimmune diseases with high unmet needs GlobeNewswire

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines - PR Newswire

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines PR Newswire

Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery - Business Wire

Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery Business Wire

Odyssey Therapeutics Appoints Nia Tatsis, Ph.D., To Board - citybiz

Odyssey Therapeutics Appoints Nia Tatsis, Ph.D., To Board citybiz

Odyssey Therapeutics Appoints Dr. William Roush as Executive Vice President - citybiz

Odyssey Therapeutics Appoints Dr. William Roush as Executive Vice President citybiz

Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer - citybiz

Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer citybiz

Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP - citybiz

Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP citybiz

Top Odyssey Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant